Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
University Hospitals Coventry and Warwickshire NHS Trust
UMC Utrecht
University Health Network, Toronto
University of Aarhus
University of Washington
Sun Yat-sen University
Ohio State University Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center
Sichuan University
University Medical Center Groningen
Nanfang Hospital, Southern Medical University